Detection of Hungarian Pandemic MRSA Clone in Russia | CMAC

Detection of Hungarian Pandemic MRSA Clone in Russia

Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(2):188-195

​ Khokhlova O.E., Hung W.-C., Higuchi W., Takano T., Peryanova O.V., Salmina A.B., Yamamoto T.
Staphylococcus aureus MRSA Hungarian clone virulence genes multiplex PCR
Section
Personal Experience
Type
Journal article
Publication
Clinical Microbiology and Antimicrobial Chemotherapy. 2011; 13(2):188-195

Abstract

Since 1961, pandemic methicillin-resistant S. aureus (MRSA) clones causing severe nosocomial infections have been distributed worldwide. The Hungarian clone having ST239 genotype and Staphylococcal cassette chromosome mec (SCCmec) type III is one of the common epidemic clones and prevalent in Russia. The rapid screening assay for Hungarian ST239-III clone using multiplex polymerase chain reaction (PCR) was proposed in this study. The PCR assay showed that the only Hungarian clone (of 10 common pandemic MRSA clones) carries a unique set of genes encoding staphylococcal enterotoxins (SE) – sea, sek and seq (it may result in severe infection and immunosupression) and can (collagen-adhesin) gene. Specific primers and probes for three virulence genes (sea, seq, can) were designed for multiplex PCR. Primers for mecA gene (to distinguish between MRSA and MSSA) and S. aureus-specific nuclease gene nuc (to distinguish between MRSA/MSSA and coagulase-negative staphylococci) were also used. This multiplex PCR assay rapidly and accurately detected Hungarian clone from Russia.

  • 1. Gordon R.J., Lowy F.D. Pathogenesis of methicillinresistant Staphylococcus aureus infection. Clin. Infect. Dis. 2008; 46(Suppl 5):350-9.
  • 2. Noto M.J., Kreiswirth B.N., Monk A.B., Archer G.L. Gene acquisition at the insertion site for SCCmec, the genomic island conferring methicillin resistance in Staphylococcus aureus. J Bacteriol 2008; 190:1276-83.
  • 3. Aires de Sousa M., Conceição T., Simas C. and Lencastre H. Comparison of genetic backgrounds of methicillinresistant and -susceptible Staphylococcus aureus isolates from Portuguese hospitals and the community. J Clin Microbiol 2005; 43:5150-7.
  • 4. Conceicao T., Aires-de-Sousa M., Füzi M., et al. Replacement of methicillin-resistant Staphylococcus aureus clones in Hungary over time: a 10-year surveillance study. Clin Microbiol Infect 2007; 13:971-9.
  • 5. Otsuka T., Saito K., Dohmae S., et al. Key adhesin gene in community-acquired methicillin-resistant Staphylococcus aureus. Biochem Biophys Res Commun 2006; 346:1234- 44.
  • 6. Takano T., Higuchi W., Otsuka T., et al. Novel characteristics of community-acquired methicillin-resistant Staphylococcus aureus strains belonging to multilocus sequence type 59 in Taiwan. Antimicrob Agents Chemother 2008; 52:837-45.
  • 7. Zhang K., Sparling J., Chow B.L., et al. New quadriplex PCR assay for detection of methicillin and mupirocin resistance and simultaneous discrimination of Staphylococcus aureus from coagulase-negative staphylococci. J Clin Microbiol 2004; 42:4947-55.
  • 8. Enright M.C., Day N.P., Davies C.E., Peacock S.J., Spratt B.G. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000; 38:1008-15.
  • 9. Oliveira D.C., de Lencastre H. Multiplex PCR strategy for rapid identification of structural types and variants of the mec element in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2002; 46:2155- 61.
  • 10. Higuchi W., Takano T., Teng L.J., Yamamoto T. Structure and specific detection of staphylococcal cassette chromosome mec type VII. Biochem Biophys Res Commun 2008; 377:752-6.
  • 11. Lowy F.D. Staphylococcus aureus infections. N Engl J Med 1998; 339:520-32.
  • 12. Takahashi N., Nishida H., Kato H., Imanishi K., Sakata Y., Uchiyama T. Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. Lancet 1998; 351:1614-9.
  • 13. Centers for Disease Control and Prevention. MRSA in Healthcare settings. updated October 3, 2007 (http://www.cdc.gov/ncidod/dhqp/ar_MRSA_spotlight_2006. html)
  • 14. Tacconelli E., Cataldo M.A. Antimicrobial therapy of Staphylococcus aureus bloodstream infection. Expert Opin Pharmacother 2007; 8:2505-18.
  • 15. Klevens R.M., Morrison M.A., Nadle J., et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763-71.
  • 16. Robinson D.A., Enright M.C. Evolutionary models of the emergence of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 2003; 47:3926-34.
  • 17. Czachor J., Herchline T. Bacteremic nonmenstrual staphylococcal toxic shock syndrome associated with enterotoxins A and C. Clin Infect Dis 2001; 32:E53-E56.
  • 18. Gravet A., Rondeau M., Harf-Monteil C., et al. Predominant Staphylococcus aureus isolated from antibiotic-associated diarrhea is clinically relevant and produces enterotoxin A and the bicomponent toxin LukE-lukD. J Clin Microbiol 1999; 37:4012-9.
  • 19. Ferry T., Thomas D., Genestier A.L., et al. Comparative prevalence of superantigen genes in Staphylococcus aureus isolates causing sepsis with and without septic shock. Clin Infect Dis 2005; 41:771-7.
  • 20. Yarwood J.M., McCormick J.K., Paustian M.L., et al. Charac­terization and expression analysis of Staphylococcus aureus pathogenicity island 3. Implications for the evolution of staphylococcal pathogenicity islands. J Biol Chem 2002; 277:138-47.
  • 21. Diep B.A., Gill S.R., Chang R.F., et al. Complete genome sequence of USA300, an epidemic clone of communityacquired meticillin-resistant Staphylococcus aureus. Lancet 2006; 367:731-9.
  • 22. Baba T., Takeuchi F., Kuroda M., et al. Genome and virulence determinants of high virulence communityacquired MRSA. Lancet. 2002; 359:1819-27.
  • 23. Diep B.A., Carleton H.A., Chang R.F., Sensabaugh G.F., Perdreau-Remington F. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis 2006; 193:1495-503.
  • 24. Takizawa Y., Taneike I., Nakagawa S., et al. PantonValentine leucocidin (PVL)-positive communityacquired methicillin-resistant Staphylococcus aureus (MRSA) strain, another such strain carrying a multipledrug resistance plasmid, and other more-typical PVLnegative MRSA strains found in Japan. J Clin Microbiol 2005; 43:3356-63.
  • 25. de Bentzmann S., Tristan A., Etienne J., et al. Staphylococcus aureus isolates associated with necrotizing pneumonia bind to basement membrane type I and IV collagens and laminin. J Infect Dis 2004; 190:1506-15.
  • 26. Elasri M.O., Thomas J.R., Skinner R.A., et al. Staphylococcus aureus collagen adhesin contributes to the pathogenesis of osteomyelitis. Bone 2002; 30:275-80.
  • 27. Patti J.M., Bremell T., Krajewska-Pietrasik D., et al. The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun 1994; 62:152-61.
Views
0 Abstract
0 PDF
0 Crossref citations
Shared